Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799107 · ClinicalTrials.gov registry record
Developmental Epidemiological Study of Children Born Through Reproductive Technology
A clinical trial of Infertility and Infertility, Female, sponsored by University of California, San Francisco.
- Active
- Registry status
- 3,700
- Enrollment target
- 1
- Study location
NCT03799107: Active study of Infertility and Infertility, Female, sponsored by University of California, San Francisco.
NCT03799107 is a study of Infertility and Infertility, Female that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 3,700 participants, below the 7,540-participant average among 74 other Infertility trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03799107, a study of Infertility and Infertility, Female, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 3,700 participants
- Enrollment target
- 1
- Study location
Study Summary
DESCRT will be a long-term study that both looks back in time, at successful pregnancies, and forward in time at early pregnancy and long-term as these children grow. Currently, there are limited data on the long-term effects of infertility and infertility treatments on children. There are some studies to suggest that these children may have altered metabolic profiles, but this study aims to be the largest study to answer this question.
Primary Outcome
Fasting glucose mg/dL
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,700 participants |
| Start Date | 2017-07-14 |
| Est. Completion | 2025-07-01 |
What the registry record for NCT03799107 still lists
NCT03799107 is an observational study that tracks outcomes without assigning an intervention. Its 3,700 participants enrollment target places it among the larger protocols in the corpus, below the 7,540-participant average among 74 other Infertility trials with a reported enrollment target (51% lower).
The record links to 6 conditions, with Infertility appearing as the primary indexed condition, and to 0 interventions.
NCT03799107 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03799107 about?
NCT03799107 is a clinical study titled "Developmental Epidemiological Study of Children Born Through Reproductive Technology". DESCRT will be a long-term study that both looks back in time, at successful pregnancies, and forward in time at early pregnancy and long-term as these children grow. Currently, there are limited data on the long-term effects of infertility and infertility treatments on children. There are some stud...
What is the current status of trial NCT03799107?
This trial is currently active not recruiting. The enrollment target is 3,700 participants. The study started on 2017-07-14. Estimated completion is 2025-07-01.
What conditions does trial NCT03799107 study?
This clinical trial studies the following conditions: Infertility, Infertility, Female, Infertility, Male, Infertility Primary, Infertility Unexplained.
Who is sponsoring clinical trial NCT03799107?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03799107 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03799107's enrollment target sits among peer trials
3,700 5th of 74 higher than 70 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI